ROYAL OSTEOPOROSIS SOCIETY

Registered charity 1102712 · accounts filings on the Charity Commission register · also known as NATIONAL OSTEOPOROSIS SOCIETY, NOS, ROS · also registered in Scotland as SC039755 (OSCR)

Latest income
£6.6m
Latest spending
£5.8m
Registered
2004
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that total income increased by 25% to £6.6m, driven largely by legacy receipts, while total expenditure remained broadly flat at £5.8m. The charity reported free reserves of £3.5m, which is £0.8m above its stated policy target of £2.7m, indicating a strong liquidity position. The trustees confirmed a reasonable expectation of continuing in operational existence with no material uncertainties identified.

What the accounts disclose

Trading subsidiary: The ROS Trading Company Limited
In addition, the charity has one wholly owned subsidiary company, The ROS Trading Company Limited, which was incorporated on 29 September 2009. — page 21
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Crowe U.K. LLP.

Public fundraising profile: JustGiving — Royal Osteoporosis Society (matched by registered charity number).

Leadership, per the charity’s website

Listed on the charity’s own website when we last crawled it; roles may have changed. Pay-band disclosures above are anonymous statutory disclosures and are not attributed to any named individual.

Structured financials (annual return, FY ending 31/12/2025)

Total income
£6.6m
Total spending
£5.8m
Cost of raising funds
£1.6m
Reserves (reported)
£5.0m
Employees
57

Reported reserves equal ~10.3 months of spending — above the median for charities its size (median 4.8 months; benchmarks).

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Guernsey · Isle Of Man · Jersey · Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2025£6.6m£5.8m
31/12/2024£5.3m£5.8m
31/12/2023£4.8m£5.4m
31/12/2022£4.7m£4.8m
31/12/2021£4.3m£3.9m

Common questions

Is ROYAL OSTEOPOROSIS SOCIETY financially healthy?

The accounts state that total income increased by 25% to £6.6m, driven largely by legacy receipts, while total expenditure remained broadly flat at £5.8m. The charity reported free reserves of £3.5m, which is £0.8m above its stated policy target of £2.7m, indicating a strong liquidity position. The trustees confirmed a reasonable expectation of continuing in operational existence with no material uncertainties identified. Its FY2025 accounts were audited by Crowe U.K. LLP.

Who funds ROYAL OSTEOPOROSIS SOCIETY?

Funders whose own accounts filings name ROYAL OSTEOPOROSIS SOCIETY as a grant recipient include THE THOMPSON FAMILY CHARITABLE TRUST, THE ORR MACKINTOSH FOUNDATION LIMITED, JOHN JAMES BRISTOL FOUNDATION, THE DAVID BROWNLOW CHARITABLE FOUNDATION, THE CADOGAN CHARITY.

Known funders

Grants to this charity found in funders’ own accounts filings.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with Royal Orthopaedic Charity.